pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 3
    aglatimagene besadenovec
    ProstAtak (aglatimagene besadenovec)
    Prostate Cancer$CADL Candel Therapeutics, Inc.
  • Marketed
    aldesleukin
    Proleukin (aldesleukin)
    Metastatic Renal Cell Carcinoma$IOVA IOVANCE BIOTHERAPEUTICS, INC.
  • Phase 3
    aldoxorubicin
    aldoxorubicin
    Metastatic Pancreatic Cancer LadRx Corp
← prev
page 40 of 62
next →
Pain89
Neurology1
Marketed
alectinib
Alecensa (alectinib)
Non-Small Cell Lung Cancer
F. Hoffmann-La Roche Ltd
  • Marketed
    alemtuzumab
    Campath (alemtuzumab)
    B-Cell Chronic Lymphocytic Leukemia Genzyme Corp
  • Phase 2
    alintegimod
    alintegimod [INN]
    Colorectal Cancer 7 Hills Pharma LLC
  • Phase 2
    alisertib
    alisertib
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$PBYI PUMA BIOTECHNOLOGY, INC.
  • Marketed
    allopurinol
    Zyloprim (allopurinol)
    Kidney Disease (Nephropathy) Casper Pharma LLC
  • Phase 2
    alnodesertib
    alnodesertib [INN]
    Metastatic Colorectal Cancer Artios Pharma Ltd
  • Marketed
    alpelisib
    Piqray (alpelisib)
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$NVS NOVARTIS AG
  • Phase 2
    alrizomadlin
    alrizomadlin [INN]
    Lung Adenocarcinoma$AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL
  • Phase 2
    amezalpat
    amezalpat [INN]
    Metastatic Hepatocellular Carcinoma (HCC)$TPST Tempest Therapeutics, Inc.
  • Marketed
    aminolevulinic acid hydrochloride
    Ameluz (aminolevulinic acid hydrochloride)
    Basal Cell Carcinoma (Basal Cell Epithelioma)$BFRI Biofrontera Inc.
  • Phase 2
    amsulostat hydrochloride
    amsulostat hydrochloride
    Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) Syntara Ltd
  • Phase 2
    amulirafusp alfa
    amulirafusp alfa [INN]
    Marginal Zone B-Cell Lymphoma ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
  • Phase 3
    anamorelin hydrochloride
    anamorelin hydrochloride
    Cancer Anorexia-Cachexia Syndrome Helsinn Healthcare SA
  • pre_registration
    anitocabtagene autoleucel
    anitocabtagene autoleucel
    Refractory Multiple Myeloma$ACLX Arcellx, Inc.
  • Phase 2
    anvatabart opadotin
    anvatabart opadotin
    Human Epidermal Growth Factor Receptor 2 Positive Breast… Ambrx Biopharma Inc
  • Phase 2
    anvumetostat
    anvumetostat [INN]
    Metastatic Biliary Tract Cancer$AMGN AMGEN INC
  • Phase 2
    anzutresgene autoleucel
    anzutresgene autoleucel [INN]
    Endometrial Cancer Immatics NV
  • Preclinical
    apomorphine palmitate
    Apomorphine palmitate
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Leukos Biotech SL
  • Phase 2
    arcotatug tavatecan
    arcotatug tavatecan [INN]
    Pancreatic Ductal Adenocarcinoma$TAK TAKEDA PHARMACEUTICAL CO LTD
  • Phase 3
    arlocabtagene autoleucel
    arlocabtagene autoleucel
    Refractory Multiple Myeloma Bristol-Myers Squibb Co
  • Phase 2
    ascrinvacumab
    ascrinvacumab
    Metastatic Hepatocellular Carcinoma (HCC) Kintor Pharmaceutical Ltd
  • Phase 2
    aspacytarabine hydrochloride
    Astarabine (aspacytarabine hydrochloride)
    Refractory Acute Myeloid Leukemia Ayala Pharmaceuticals Inc.
  • Phase 2
    atebimetinib
    atebimetinib [INN]
    Bile Duct Cancer (Cholangiocarcinoma)$IMRX Immuneering Corp
  • Phase 2
    ateganosine
    ateganosine
    Non-Small Cell Lung Cancer$MAIA MAIA Biotechnology, Inc.
  • Phase 2
    autogene cevumeran
    autogene cevumeran
    Solid Tumor Genentech Inc
  • Marketed
    avapritinib
    Ayvakit (avapritinib)
    Gastrointestinal Stromal Tumor (GIST) Blueprint Medicines Corp
  • Marketed
    avutometinib potassium
    avutometinib potassium
    Fallopian Tube Cancer$VSTM Verastem, Inc.